Investigation of the Effect of Acceptance and Commitment Therapy-Based Intervention in Oncology Patients

NCT ID: NCT06457178

Last Updated: 2025-06-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

75 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-06-01

Study Completion Date

2026-01-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to investigate the effectiveness of Acceptance and Commitment Therapy Based Intervention for Oncology Patients. The main questions it aims to answer are:

* Does the Acceptance and Commitment to Therapy-Based Intervention for Oncology Patients affect the level of psychological distress?
* Does the Acceptance and Commitment to Therapy-Based Intervention for Oncology Patients affect the level of reintegration into normal life?

Researchers will compare Acceptance and Commitment Therapy-Based Intervention for Oncology Patients (ACT) to Psychoeducation for Oncology Patients and routine care (with no specific intervention) to see if Acceptance and Commitment Therapy-Based Intervention for Oncology Patients is effective in psychological distress and reintegration into normal living.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Participants:

* They will be randomly divided into three groups (Group 1: ACT, Group 2: Psychoeducation, Group 3: Routine care).
* All participants will be asked to complete data collection forms.
* Group 1 will participate in a 5-session Acceptance and Commitment Therapy-Based Intervention for Oncology Patients intervention program.
* Group 2 will participate in a 5-session Psychoeducation for Oncology Patients program.
* During this period, participants in group 3 will continue their routine treatment.
* After completion of the interventions, participants will be asked to complete the data collection forms again.
* The researchers will then analyze the results and write the report.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acceptance and Commitment Therapy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Acceptance and Commitment Therapy Based Intervention for Oncology Patients

Group 1 will participate in a 5-session Acceptance and Commitment Therapy-Based Intervention for Oncology Patients intervention program.

Group Type EXPERIMENTAL

Acceptance and Commitment Therapy-Based Intervention for Oncology Patients

Intervention Type BEHAVIORAL

An intervention program was prepared for oncology patients aiming to reduce psychological distress and increase participation in normal life.

Psychoeducation for Oncology Patients

Group 2 will participate in a 5-session Psychoeducation for Oncology Patients program.

Group Type ACTIVE_COMPARATOR

Psychoeducation for Oncology Patients

Intervention Type BEHAVIORAL

A program was prepared to support oncology patients in physical and psychological symptom management.

Routine Care

During this period, participants in group 3 will continue their routine treatment.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Acceptance and Commitment Therapy-Based Intervention for Oncology Patients

An intervention program was prepared for oncology patients aiming to reduce psychological distress and increase participation in normal life.

Intervention Type BEHAVIORAL

Psychoeducation for Oncology Patients

A program was prepared to support oncology patients in physical and psychological symptom management.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 years of age or older,
* Being able to read and write,
* Receiving oncologic treatment,
* Being diagnosed with breast cancer,
* To know about Medical Diagnosis,
* Being in stage 1, 2 or 3 of the disease,
* Receiving outpatient chemotherapy treatment only,
* Internet access and computer skills to participate in online group interviews,
* Low to moderate scores on the brief psychological resilience scale,

Exclusion Criteria

* Having serious psychiatric or cognitive impairments that limit adherence to group sessions,
* Having a physical disability that may make it difficult to participate in group sessions,
* Failure to attend sessions regularly and absenteeism,
* Currently being in a psychoeducation/psychotherapy group
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Istanbul University - Cerrahpasa

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dilara Sert Kasım

Doctorate Student

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Dilara Sert Kasım, M.Sc.

Role: PRINCIPAL_INVESTIGATOR

Istanbul University - Cerrahpasa

Hülya Bilgin, Ph.D.

Role: PRINCIPAL_INVESTIGATOR

Istanbul University - Cerrahpasa

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Acibadem Hospital

Istanbul, , Turkey (Türkiye)

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Dilara Sert Kasım, M.Sc.

Role: CONTACT

(+90) 541 267 95 25

Hülya Bilgin, Ph.D.

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Dilara Sert Kasım

Role: primary

05412679525

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IstanbulUC-DSKasım-001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

A Mindfulness-Based Self-Compassion Program
NCT06846060 NOT_YET_RECRUITING NA